CYTOKINETICS, INCORPORATED Payments of Stock Issuance Costs
CYTOKINETICS, INCORPORATED (CYTK) reported Payments of Stock Issuance Costs of $2.80 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2017-03-06
- CYTOKINETICS, INCORPORATED payments of stock issuance costs for fiscal 2014 was $2.80M, a 30.00% decline from fiscal 2013.
- CYTOKINETICS, INCORPORATED payments of stock issuance costs for fiscal 2013 was $4.00M, a 87.00% increase from fiscal 2012.
- CYTOKINETICS, INCORPORATED payments of stock issuance costs for fiscal 2012 was $2.14M, a 3935.85% increase from fiscal 2011.
- CYTOKINETICS, INCORPORATED payments of stock issuance costs for fiscal 2011 was $53.00K.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|
| 2014-12-31 | $2.80M 10-K · filed 2017-03-06 | ||
| 2013-12-31 | $4.00M 10-K · filed 2014-03-07 | ||
| 2012-12-31 | $2.14M 10-K · filed 2015-03-06 | $4.00M 10-K · filed 2013-03-15 | |
| 2012-06-25 | $4.00M 10-K · filed 2017-03-06 | ||
| 2011-12-31 | $53.00K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |